This webinar will explore the motivation, process, and key conclusions behind the recently published “Clinical Guideline for the Diagnosis and Treatment of Fibrolamellar Carcinoma” in the journal Hepatology. Several of the guideline authors will present the work, share their insights from the development process, and respond to questions.
Topics to be addressed include:
- Why these clinical guidelines were developed and published
- How the guidelines were created and consensus was achieved
- The most important findings and recommendations from the effort.
This Zoom webinar will take place at 7:00 pm Eastern time / 4:00 pm Pacific time.
Moderator:
- Mark Furth, PhD
Chief Science Officer, FCF
Panelists:
- Allison O’Neill, MD
Dana-Farber Cancer Institute
Boston Children’s Hospital - John Gordan, MD, PhD
University of California, San Francisco - Kimberly Riehle, MD, FACS, FAAP
UW Medicine
Seattle Children’s Hospital - William Harris, MD
UW Medicine
Fred Hutchinson Cancer Center
- Mark Yarchoan, MD
Johns Hopkins Medicine
Invited audience:
Any fibrolamellar patients, caregivers and clinicians interested in learning more about these newly published guidelines!
Please click here to register for the event.